等待开盘 04-19 09:30:00 美东时间
-0.200
-0.70%
生物医药 行业的寒冬还未过去,但已经迎来了曙光。 对于生物医药行业而言,虽然当下是行业的谷底,但是也是行业厚积薄发,兼并收购最好的时机。 过去的两年里,由于加息...
04-18 10:05
Ratings for BioNTech (NASDAQ:BNTX) were provided by 11 analysts in the past thr...
04-17 22:00
Genmab (Otc) (GMAB) has released an update. Genmab A/S reported robust first qu...
04-16 22:27
Reporting its Q1 2024 results, Big Pharma’s earnings bellwether, Johnson & Johnson (NYSE:JNJ), revised its full-year outlook below consensus on Tuesday after sales from its MedTech division fell short...
04-16 19:20
自2023年以來,港股市場的生物科技企業感受到了徹骨的寒意,不少公司的股價遭遇了大幅下挫,跌成了渣。 Wind數據顯示,2023年至今(截至4月11日),健世科...
04-12 15:53
转自:澎湃新闻 “魔法子弹”抗体偶联药物(ADC)依然是近期医药行业的热门话题,除了适应证的竞争,产能也正在成为ADC赛道玩家的一大竞争点。 4月10日...
04-10 20:36
俩月赚4倍,最快退出诞生了。 130亿交易落地,这次轮到20多家投资机构庆祝了。 前几日,创新药巨头Genmab发布公告称,将以18亿美元(约13...
04-09 08:30
Genmab (Otc) (GMAB) has released an update. Genmab A/S, the Danish biotechnolog...
04-09 02:28
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months By Doug Young
04-08 23:43